| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008799479 |
| P356 | DOI | 10.1038/386830A0 |
| P698 | PubMed publication ID | 9126741 |
| P5875 | ResearchGate publication ID | 14091077 |
| P2093 | author name string | Wang GJ | |
| Fowler JS | |||
| Gatley SJ | |||
| Hitzemann R | |||
| Logan J | |||
| Volkow ND | |||
| Pappas N | |||
| Dewey SL | |||
| Chen AD | |||
| P2860 | cites work | Neurophysiological, pharmacological and behavioral evidence for medial thalamic mediation of cocaine-induced dopaminergic analgesia | Q48528537 |
| Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices | Q49065832 | ||
| Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain. | Q51616766 | ||
| Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution. | Q51621295 | ||
| Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. | Q51813794 | ||
| Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients | Q72139120 | ||
| Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain | Q72700464 | ||
| Cellular and molecular mechanisms of drug dependence | Q28283898 | ||
| Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs | Q29301836 | ||
| The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 | ||
| Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
| Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects | Q34356874 | ||
| The problem of the frontal lobe: a reinterpretation | Q34701092 | ||
| Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain | Q34722461 | ||
| Toward a neuroanatomy of obsessive-compulsive disorder | Q35775985 | ||
| Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data | Q36723875 | ||
| Basal ganglia/limbic striatal and thalamocortical involvement in craving and loss of control in alcoholism | Q37616922 | ||
| New concepts in cocaine addiction: the dopamine depletion hypothesis | Q39497896 | ||
| Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures | Q42455732 | ||
| Imaging endogenous dopamine competition with [11C]raclopride in the human brain | Q42496463 | ||
| Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain | Q45248583 | ||
| Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography | Q48121127 | ||
| Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers | Q48279855 | ||
| Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels | Q48309259 | ||
| Studies on the caudate-putamen and the dorsomedial thalamic nucleus of the rat: Implications for mammalian frontal-lobe functions | Q48317144 | ||
| Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes | Q48336267 | ||
| P433 | issue | 6627 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| striatum | Q1319792 | ||
| P304 | page(s) | 830-833 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects | |
| P478 | volume | 386 |
| Q24197685 | Q24197685 |
| Q36821795 | A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration |
| Q33861946 | A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum |
| Q48394205 | A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation |
| Q50913804 | A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning. |
| Q33964638 | A linear model for estimation of neurotransmitter response profiles from dynamic PET data |
| Q45918856 | A neurocomputational model for cocaine addiction. |
| Q42540010 | A novel strategy for the treatment of cocaine addiction |
| Q37082564 | A somatic marker theory of addiction |
| Q35065687 | Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence |
| Q37352917 | Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys |
| Q34096632 | Abstinence from cocaine and sucrose self-administration reveals altered mesocorticolimbic circuit connectivity by resting state MRI. |
| Q34411360 | Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. |
| Q35745285 | Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function |
| Q46701574 | Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol |
| Q48618466 | Acute effects of cocaine on human brain activity and emotion |
| Q35203630 | Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats |
| Q34452916 | Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. |
| Q30622498 | Addiction and choice: theory and new data |
| Q32033759 | Addiction and imaging of the living human brain |
| Q91525194 | Addiction as a brain disease does not promote injustice |
| Q22251251 | Addiction science: Uncovering neurobiological complexity |
| Q36741908 | Addiction: the clinical interface |
| Q35035878 | Addictive potential of cannabinoids: the underlying neurobiology |
| Q44334537 | Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III seven-repeat allele and substance abuse in opioid dependent subjects: relationship of treatment retention to genotype and personality |
| Q37172714 | Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter. |
| Q34459800 | Adolescence: what do transmission, transition, and translation have to do with it? |
| Q35783139 | Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems |
| Q47305133 | Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. |
| Q35179039 | Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain |
| Q28537648 | Amphetamine sensitization alters reward processing in the human striatum and amygdala. |
| Q37334774 | An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers |
| Q42728896 | Anhedonia and substance dependence: clinical correlates and treatment options. |
| Q34424644 | Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study |
| Q30433958 | Animal models of substance abuse and addiction: implications for science, animal welfare, and society |
| Q24234248 | Antidepressants for cocaine dependence and problematic cocaine use |
| Q43890290 | Apathy syndrome in cocaine dependence |
| Q43764922 | Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition |
| Q26865012 | Application of cross-species PET imaging to assess neurotransmitter release in brain |
| Q47437020 | Application of fast-scan cyclic voltammetry for the in vivo characterization of optically evoked dopamine in the olfactory tubercle of the rat brain |
| Q34318601 | Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? |
| Q28185910 | Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review |
| Q34980182 | Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence |
| Q38744676 | Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis |
| Q33855974 | BMI modulates calorie-dependent dopamine changes in accumbens from glucose intake |
| Q37356877 | Behavioral and neurological foundations for the moral and legal implications of intoxication, addictive behaviors and disinhibition |
| Q36530551 | Betel quid dependence is associated with functional connectivity changes of the anterior cingulate cortex: a resting-state fMRI study |
| Q30376046 | Bilateral Transcranial Magnetic Stimulation of the Prefrontal Cortex Reduces Cocaine Intake: A Pilot Study |
| Q44506497 | Biological markers of cocaine addiction: implications for medications development |
| Q48451252 | Blockade of cue-induced brain activation of abstinent alcoholics by a single administration of amisulpride as measured with fMRI. |
| Q44445337 | Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users |
| Q37660664 | Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents |
| Q34577804 | Brain activity and desire for Internet video game play |
| Q31131085 | Brain imaging research: does the science serve clinical practice? |
| Q40081464 | Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence |
| Q40650415 | Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder |
| Q37485715 | Carrots and sticks fail to change behavior in cocaine addiction |
| Q52275787 | Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. |
| Q34429452 | Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory |
| Q42379921 | Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography |
| Q31431986 | Cerebral perfusion abnormalities in abstinent cocaine abusers: a perfusion MRI and SPECT study. |
| Q34435906 | Changes in gene expression and signal transduction following ibogaine treatment |
| Q35642558 | Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine |
| Q37208488 | Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling |
| Q41944708 | Chronic exposure to a gambling-like schedule of reward predictive stimuli can promote sensitization to amphetamine in rats |
| Q90416610 | Chronic forced exercise inhibits stress-induced reinstatement of cocaine conditioned place preference |
| Q34875333 | Chronic stress, drug use, and vulnerability to addiction |
| Q35839390 | Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. |
| Q48414078 | Cocaine Addiction: Neurobiology and Related Current Research in Pharmacotherapy |
| Q37127823 | Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine |
| Q30540379 | Cocaine abstinence alters nucleus accumbens firing dynamics during goal-directed behaviors for cocaine and sucrose |
| Q33936013 | Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28. |
| Q73593193 | Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions |
| Q40087440 | Cocaine addiction is associated with abnormal prefrontal function, increased striatal connectivity and sensitivity to monetary incentives, and decreased connectivity outside the human reward circuit |
| Q44793037 | Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. |
| Q41889137 | Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. |
| Q33858028 | Cocaine self-administration in dopamine-transporter knockout mice |
| Q36619463 | Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction |
| Q57647154 | Cocaína y cerebro |
| Q37965451 | Cognitive control and the dopamine D₂-like receptor: a dimensional understanding of addiction |
| Q45126961 | Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance |
| Q28283168 | Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective |
| Q37082569 | Conditioned cues and the expression of stimulant sensitization in animals and humans |
| Q30419977 | Connecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides |
| Q28584883 | Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow |
| Q34004896 | Contributions of neuroimaging to understanding sex differences in cocaine abuse |
| Q37691329 | Cortical and sub-cortical effects in primate models of cocaine use: implications for addiction and the increased risk of psychiatric illness |
| Q34018269 | Covalent modification of proteins by cocaine |
| Q30664549 | Craving for alcohol and drugs in animals and humans: biology and behavior |
| Q60939085 | Cross-Sectional and Longitudinal Evaluation of the Social Network Use Disorder and Internet Gaming Disorder Criteria |
| Q48009353 | Cross-talk between the epigenome and neural circuits in drug addiction. |
| Q35680896 | Decreased dopamine activity predicts relapse in methamphetamine abusers |
| Q34002281 | Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity |
| Q46423388 | Decreased neural activity in reward circuitry during personal reference in abstinent alcoholics--a fMRI study |
| Q34765909 | Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates |
| Q56336098 | Deep brain stimulation for the treatment of drug addiction |
| Q35661488 | Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction |
| Q43884686 | Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique |
| Q34768278 | Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, met |
| Q40896760 | Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine |
| Q43167714 | Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter |
| Q36286365 | Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling |
| Q34444410 | Disordered gambling: the evolving concept of behavioral addiction |
| Q30481200 | Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers |
| Q34277944 | Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies |
| Q43728694 | Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression |
| Q42642584 | Dopamine D2 Receptors in the Paraventricular Thalamus Attenuate Cocaine Locomotor Sensitization. |
| Q44593446 | Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography |
| Q33697312 | Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development. |
| Q33809050 | Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO. |
| Q42134434 | Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? |
| Q24187799 | Dopamine agonists for the treatment of cocaine dependence |
| Q24234240 | Dopamine agonists for the treatment of cocaine dependence |
| Q34082931 | Dopamine challenge reveals neuroadaptive changes in marijuana abusers |
| Q27337060 | Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers |
| Q35751195 | Dopamine in drug abuse and addiction: results from imaging studies and treatment implications |
| Q35205766 | Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. |
| Q28543414 | Dopamine receptor activation increases HIV entry into primary human macrophages |
| Q33983589 | Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration |
| Q35857033 | Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study |
| Q44804073 | Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. |
| Q37821386 | Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse |
| Q30488704 | Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention |
| Q37385723 | Dopaminergic activity in depressed smokers: a positron emission tomography study. |
| Q35200020 | Dopaminergic system dysfunction in recreational dexamphetamine users |
| Q29619998 | Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex |
| Q48227049 | Drug addiction: bad habits add up. |
| Q35145903 | Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. |
| Q33660418 | Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats |
| Q38207705 | Drugs currently in Phase II clinical trials for cocaine addiction |
| Q24641896 | Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction |
| Q38289607 | Early-life adversity and adolescent depression: mechanisms involving the ventral striatum |
| Q37018136 | Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys |
| Q64286258 | Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability |
| Q44245935 | Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study |
| Q24655301 | Effects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys |
| Q73222783 | Effects of selegiline pretreatment on response to experimental cocaine administration |
| Q37281925 | Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers |
| Q30362023 | Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. |
| Q24239994 | Efficacy of Psychostimulant Drugs for Cocaine Dependence |
| Q24240730 | Efficacy of Psychostimulant Drugs for Cocaine Dependence |
| Q24242579 | Efficacy of Psychostimulant Drugs for Cocaine Dependence |
| Q40876310 | Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. |
| Q38030488 | Emerging association between addictive gaming and attention-deficit/hyperactivity disorder |
| Q36726621 | Emotion, decision-making and substance dependence: a somatic-marker model of addiction |
| Q30490121 | Enhanced choice for viewing cocaine pictures in cocaine addiction. |
| Q53080594 | Enhanced neuronal and blunted hemodynamic reactivity to cocaine in the prefrontal cortex following extended cocaine access: optical imaging study in anesthetized rats. |
| Q38332302 | Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice. |
| Q37942815 | Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management |
| Q64247538 | Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder |
| Q44691586 | Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. |
| Q34314230 | Expectation of caffeine induces dopaminergic responses in humans |
| Q36850061 | Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests |
| Q37626216 | Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine |
| Q42069029 | Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex |
| Q42510225 | Extracellular dopamine, acetylcholine, and activation of dopamine D1 and D2 receptors after selective breeding for cocaine self-administration in rats. |
| Q36813731 | Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders |
| Q28084960 | Food reward system: current perspectives and future research needs |
| Q47099780 | Food-Predicting Stimuli Differentially Influence Eye Movements and Goal-Directed Behavior in Normal-Weight, Overweight, and Obese Individuals |
| Q37590636 | Food-addiction scale measurement in 2 cohorts of middle-aged and older women |
| Q37184297 | Fronto-striatal dysregulation in drug addiction and pathological gambling: Consistent inconsistencies? |
| Q51561316 | Frontostriatal circuits, resting state functional connectivity and cognitive control in internet gaming disorder. |
| Q64960554 | Functional Connectivity of Chronic Cocaine Use Reveals Progressive Neuroadaptations in Neocortical, Striatal, and Limbic Networks. |
| Q30833169 | Functional and structural brain changes associated with methamphetamine abuse |
| Q30572554 | Functional changes of the reward system underlie blunted response to social gaze in cocaine users. |
| Q37628349 | Functional connectivity of substantia nigra and ventral tegmental area: maturation during adolescence and effects of ADHD. |
| Q30602026 | Functional imaging of craving. |
| Q22242633 | Future pharmacological treatments for substance use disorders |
| Q92186073 | Gambling disorder |
| Q38538921 | Games in the Brain: Neural Substrates of Gambling Addiction |
| Q36928468 | Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence |
| Q35080147 | Gene x disease interaction on orbitofrontal gray matter in cocaine addiction |
| Q35781505 | Gene-gene interaction associated with neural reward sensitivity |
| Q38893386 | Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. |
| Q36547837 | Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome |
| Q48207687 | Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study |
| Q41654655 | High fat diet augments amphetamine sensitization in mice: Role of feeding pattern, obesity, and dopamine terminal changes |
| Q36460012 | How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal |
| Q37615648 | How to design PET experiments to study neurochemistry: application to alcoholism |
| Q30422045 | Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity |
| Q33805237 | Imaging brain response to reward in addictive disorders |
| Q42602956 | Imaging cortical dopamine concentrations, at last! Application to the neurobiology of alcohol dependence |
| Q35607225 | Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment |
| Q36997098 | Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study. |
| Q37212526 | Imaging dopamine's role in drug abuse and addiction |
| Q35990231 | Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. |
| Q43721371 | Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum |
| Q34355244 | Imaging neurochemical endophenotypes: promises and pitfalls |
| Q36164564 | Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study |
| Q91621387 | Imaging phosphodiesterase-10a availability in cocaine use disorder with [11 C]IMA107 and PET |
| Q37140457 | Imaging receptor changes in human drug abusers |
| Q33833634 | Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans |
| Q33867444 | Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review |
| Q36136737 | Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism |
| Q39768071 | Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers. |
| Q35044767 | Impaired neural response to negative prediction errors in cocaine addiction. |
| Q58299860 | Important Factors of Early Addiction Recovery and Inpatient Treatment |
| Q34442240 | Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation |
| Q48812192 | In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. |
| Q36118252 | In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers |
| Q42681094 | In vivo ibogaine blockade and in vitro PKC action of cocaine |
| Q35990520 | Increased Orbitofrontal Brain Activation after Administration of a Selective Adenosine A(2A) Antagonist in Cocaine Dependent Subjects |
| Q48383626 | Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats |
| Q33872563 | Increased error-related thalamic activity during early compared to late cocaine abstinence |
| Q45332091 | Increased response conflict in recreational cocaine polydrug users |
| Q37394240 | Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users |
| Q34304643 | Increased vulnerability to cocaine in mice lacking dopamine D3 receptors |
| Q47849545 | Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans |
| Q34203887 | Individual differences in prefrontal cortex function and the transition from drug use to drug dependence |
| Q47150637 | Individual differences in the neuropsychopathology of addiction |
| Q37104453 | Individual predictors of the subjective effects of intravenous cocaine |
| Q36489516 | Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction |
| Q42475664 | Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls |
| Q34803278 | Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET |
| Q30453617 | Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence |
| Q34377561 | L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons |
| Q28372074 | Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients |
| Q48249065 | Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex. |
| Q44343162 | Long-term effects of maternal separation on ethanol intake and brain opioid and dopamine receptors in male wistar rats |
| Q28389867 | Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development |
| Q47340187 | Longitudinal Changes in Brain Metabolic Activity after Withdrawal from Escalation of Cocaine Self-Administration. |
| Q47923439 | Low startle magnitude may be a behavioral marker of vulnerability to cocaine addiction |
| Q28257109 | Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion |
| Q89819832 | Mechanisms of Shared Vulnerability to Post-traumatic Stress Disorder and Substance Use Disorders |
| Q35928660 | Mesolimbic recruitment by nondrug rewards in detoxified alcoholics: effort anticipation, reward anticipation, and reward delivery |
| Q48165019 | Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain |
| Q33634061 | Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers |
| Q90036901 | Methylphenidate's effects on thalamic metabolism and functional connectivity in cannabis abusers and healthy controls |
| Q35954857 | Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder |
| Q37146811 | Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users |
| Q59800039 | Mindfulness meditation in the treatment of substance use disorders and preventing future relapse: neurocognitive mechanisms and clinical implications |
| Q34459309 | Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. |
| Q44394305 | Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study |
| Q38212402 | Molecular neuroimaging: the basics |
| Q36290209 | Motivational Effects of Methylphenidate are Associated with GABRA2 Variants Conferring Addiction Risk |
| Q100423058 | Multimodal investigation of dopamine D2/D3 receptors, default mode network suppression, and cognitive control in cocaine-use disorder |
| Q35174502 | Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors |
| Q43825625 | NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans |
| Q35798687 | Negative reinforcement learning is affected in substance dependence |
| Q42579424 | Neural Correlates of Exposure to Cocaine Cues in Rhesus Monkeys: Modulation by the Dopamine Transporter |
| Q48189294 | Neural Mechanisms of Circadian Regulation of Natural and Drug Reward |
| Q37021965 | Neural Plasticity, Human Genetics, and Risk for Alcohol Dependence |
| Q90612736 | Neural and neurocognitive markers of vulnerability to gambling disorder: a study of unaffected siblings |
| Q35454766 | Neural basis of reward and craving--a homeostatic point of view. |
| Q37693705 | Neural correlates of food addiction |
| Q24648658 | Neural substrates of cognitive inflexibility after chronic cocaine exposure |
| Q36777473 | Neural vulnerability factors that increase risk for future weight gain |
| Q26774129 | Neurobiologic Advances from the Brain Disease Model of Addiction |
| Q35894612 | Neurobiologic processes in drug reward and addiction |
| Q37088658 | Neurobiological substrates for the dark side of compulsivity in addiction |
| Q34535855 | Neurobiology of addiction: a neurocircuitry analysis |
| Q38982604 | Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder |
| Q48193853 | Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers |
| Q24647156 | Neurocircuitry of addiction |
| Q31440279 | Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients. |
| Q35761494 | Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity |
| Q24631230 | Neuroimaging and drug taking in primates |
| Q57738781 | Neuroimaging bei Substanzabhängigkeit |
| Q38714755 | Neuroimaging evidence of altered fronto-cortical and striatal function after prolonged cocaine self-administration in the rat. |
| Q27014859 | Neuroimaging for drug addiction and related behaviors |
| Q35294724 | Neuroimaging in drug abuse. |
| Q91436965 | Neuroimaging of reward mechanisms in Gambling disorder: an integrative review |
| Q35978341 | Neurologically plausible distinctions in cognition relevant to drug use etiology and prevention |
| Q44496345 | Neuropsychological effects associated with recreational cocaine use. |
| Q36314030 | Neuroreceptor imaging in psychiatry: theory and applications. |
| Q33401122 | Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: comparison with in-vivo microdialysis data |
| Q33383360 | Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction |
| Q26827446 | Obesity and addiction: neurobiological overlaps |
| Q38657025 | On cue: striatal ups and downs in addictions |
| Q37024191 | Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology |
| Q27335194 | Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers: association to striatal D2/D3 receptors |
| Q31033080 | PET Neurochemical Imaging Modes. |
| Q48434245 | PET imaging studies in drug abuse |
| Q30403978 | PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations |
| Q48219140 | PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756. |
| Q37381883 | Pathological choice: the neuroscience of gambling and gambling addiction |
| Q37010911 | Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. |
| Q37679140 | Personality traits and vulnerability or resilience to substance use disorders. |
| Q34982551 | Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine |
| Q34242078 | Pharmacotherapeutic approach to the treatment of addiction: persistent challenges |
| Q34253787 | Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. |
| Q35576598 | Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. |
| Q26829186 | Pharmacotherapy for stimulant-related disorders |
| Q33880993 | Phasic dopamine release in appetitive behaviors and drug addiction |
| Q35692932 | Positron emission tomography radiochemistry |
| Q51459211 | Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats. |
| Q57498817 | Prescription Opioid Analgesics Increase Risk of Major Depression: New Evidence, Plausible Neurobiological Mechanisms and Management to Achieve Depression Prophylaxis |
| Q90038947 | Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury |
| Q48286276 | Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal. |
| Q46899798 | Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement |
| Q28508907 | Profound neuronal plasticity in response to inactivation of the dopamine transporter |
| Q38833164 | Psychological and Neurobiological Correlates of Food Addiction |
| Q38964799 | Psychostimulant drugs for cocaine dependence. |
| Q36211464 | Psychostimulants, madness, memory... and RGS proteins? |
| Q38056059 | Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders |
| Q47385116 | Received View of Addiction, Relapse and Treatment |
| Q35910290 | Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders |
| Q37604557 | Recovering from cocaine: insights from clinical and preclinical investigations |
| Q45258415 | Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. |
| Q48346301 | Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder |
| Q28081107 | Regulation of dopamine system responsivity and its adaptive and pathological response to stress |
| Q36565615 | Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release |
| Q91525204 | Reply to 'Addiction as a brain disease does not promote injustice' |
| Q35010421 | Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptors |
| Q58700126 | Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA |
| Q37024157 | Review. Neurobiological mechanisms for opponent motivational processes in addiction |
| Q34798207 | Review. The incentive sensitization theory of addiction: some current issues |
| Q38903075 | Reward Processing, Neuroeconomics, and Psychopathology |
| Q59292055 | Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings |
| Q26744416 | Reward deficiency and anti-reward in pain chronification |
| Q30462673 | Reward processing in autism: a thematic series |
| Q34108815 | Risk assessment and reward processing in problem gambling investigated by event-related potentials and fMRI-constrained source analysis. |
| Q27306943 | Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults |
| Q47553353 | Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. |
| Q37228046 | Role of dopamine in the motivational and cognitive control of behavior |
| Q40461748 | Role of gustatory thalamus in anticipation and comparison of rewards over time in rats. |
| Q42162248 | SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice |
| Q52316241 | Selectivity of probes for PET imaging of dopamine D3 receptors. |
| Q48339779 | Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal |
| Q36176691 | Sensitization, drug addiction and psychopathology in animals and humans |
| Q90575790 | Separating dopamine D2 and D3 receptor sources of [11C]-(+)-PHNO binding potential: Independent component analysis of competitive binding |
| Q91586672 | Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers |
| Q37047922 | Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis |
| Q36900876 | Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? |
| Q30445824 | Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. |
| Q43075618 | Similarities and Differences in Neurobiology |
| Q47251423 | Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study. |
| Q37262032 | Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. |
| Q27324741 | Social dominance in rats: effects on cocaine self-administration, novelty reactivity and dopamine receptor binding and content in the striatum |
| Q36786552 | Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers |
| Q36468351 | Stimulus-response learning in long-term cocaine users: acquired equivalence and probabilistic category learning |
| Q37477692 | Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit |
| Q36496045 | Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. |
| Q56992653 | Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status |
| Q36223850 | Striatal dopamine D₂/D₃ receptor binding in pathological gambling is correlated with mood-related impulsivity |
| Q34028727 | Striatal dopamine release in schizophrenia comorbid with substance dependence |
| Q47583470 | Striatal dopaminergic reward response relates to age of first drunkenness and feedback response in at-risk youth |
| Q34554828 | Striatal ups and downs: their roles in vulnerability to addictions in humans |
| Q33772001 | Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance |
| Q30578245 | Striatocortical pathway dysfunction in addiction and obesity: differences and similarities |
| Q61807183 | Structural and Functional Alterations in Betel-Quid Chewers: A Systematic Review of Neuroimaging Findings |
| Q74151392 | Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: new dopamine transporter inhibitors |
| Q43803552 | Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter |
| Q33620604 | Temporal difference error prediction signal dysregulation in cocaine dependence |
| Q30496711 | Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception |
| Q48286844 | The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. |
| Q37220703 | The Iowa Gambling Task and the three fallacies of dopamine in gambling disorder |
| Q36894533 | The Roles of Dopamine and α1-Adrenergic Receptors in Cocaine Preferences in Female and Male Rats |
| Q30794301 | The addicted human brain: insights from imaging studies |
| Q33455500 | The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction |
| Q36377851 | The detrimental effects of emotional process dysregulation on decision-making in substance dependence |
| Q27026331 | The development, past achievements, and future directions of brain PET |
| Q47761117 | The dopamine D2 receptor mediates approach-avoidance tendencies in smokers |
| Q22251015 | The dopamine theory of addiction: 40 years of highs and lows |
| Q37500893 | The dopaminergic basis of human behaviors: A review of molecular imaging studies |
| Q36248846 | The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q43075979 | The genetic epidemiology of substance use disorder: A review |
| Q34420287 | The measurement of craving |
| Q30392185 | The motivational salience of cigarette-related stimuli among former, never, and current smokers. |
| Q28236333 | The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans |
| Q57513959 | The role of GABAB receptors in depression and antidepressant-related behavioural responses |
| Q53828206 | The role of catecholamines in HIV neuropathogenesis. |
| Q34658860 | The role of dopamine for the pathophysiology of schizophrenia |
| Q34641435 | The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats |
| Q36511717 | The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology |
| Q52304391 | Therapeutic doses of buspirone block D3 receptors in the living primate brain. |
| Q37369444 | Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects |
| Q60907343 | Time-dependent assessment of stimulus-evoked regional dopamine release |
| Q34660666 | Tolcapone suppresses ethanol intake in alcohol-preferring rats performing a novel cued access protocol |
| Q37177694 | Towards a 'Sociorelational' Approach to Conceptualizing and Managing Addiction |
| Q55333925 | Transcranial magnetic stimulation for the treatment of cocaine addiction: evidence to date. |
| Q45283043 | Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function |
| Q45176534 | Two new neurophysiological indices of cocaine craving: evoked brain potentials and cue modulated startle reflex |
| Q37029346 | Unbalanced neuronal circuits in addiction |
| Q52188264 | Understanding and preventing substance abuse by adolescents: a guide for primary care clinicians. |
| Q38680773 | Utility of Nonhuman Primates in Substance Use Disorders Research |
| Q35195505 | What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? |
| Q29618655 | What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? |
| Q38103659 | When a good taste turns bad: Neural mechanisms underlying the emergence of negative affect and associated natural reward devaluation by cocaine. |
| Q30500107 | Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence |
| Q30473348 | fMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia |
| Q37419907 | fMRI response in the medial prefrontal cortex predicts cocaine but not sucrose self-administration history |
Search more.